Literature DB >> 15165100

Effect of gefitinib (ZD1839) on metastatic brain tumour.

Hidenori Takahashi, Takashi Ohrui, Satoru Ebihara, Mitsuhiro Yamada, Hidetada Sasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15165100     DOI： 10.1016/j.lungcan.2003.09.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  6 in total

1.  Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Authors:  Jumpei Kashima; Yusuke Okuma; Maki Miwa; Yukio Hosomi
Journal:  Med Oncol       Date:  2016-10-18       Impact factor: 3.064

2.  EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib.

Authors:  Shinji Shimato; Tetsuya Mitsudomi; Takayuki Kosaka; Yasushi Yatabe; Toshihiko Wakabayashi; Masaaki Mizuno; Norimoto Nakahara; Hisashi Hatano; Atsushi Natsume; Dai Ishii; Jun Yoshida
Journal:  Neuro Oncol       Date:  2006-01-20       Impact factor: 12.300

Review 3.  Oral Targeted Therapies and Central Nervous System (CNS) Metastases.

Authors:  Michael P Gabay; Scott M Wirth; Joan M Stachnik; Colleen L Overley; Katie E Long; Linda R Bressler; John L Villano
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

4.  Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy.

Authors:  Yin-Duo Zeng; Hai Liao; Tao Qin; Li Zhang; Wei-Dong Wei; Jian-Zhong Liang; Fei Xu; Xiao-Xiao Dinglin; Shu-Xiang Ma; Li-Kun Chen
Journal:  Oncotarget       Date:  2015-04-10

5.  Prophylactic Cranial Irradiation in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Karine A Al Feghali; Rami A Ballout; Assem M Khamis; Elie A Akl; Fady B Geara
Journal:  Front Oncol       Date:  2018-04-20       Impact factor: 6.244

6.  A comparative analysis of EGFR mutation status in association with the efficacy of TKI in combination with WBRT/SRS/surgery plus chemotherapy in brain metastasis from non-small cell lung cancer.

Authors:  Ling Cai; Jian-fei Zhu; Xue-wen Zhang; Su-xia Lin; Xiao-dong Su; Peng Lin; Kai Chen; Lan-jun Zhang
Journal:  J Neurooncol       Date:  2014-08-07       Impact factor: 4.130
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.